%0 English Abstract
%T [Our enemy : the clot. Coronary thrombosis : strategy and therapeutic arsenal].
%A du Fretay XH
%A Deballon R
%A Carillo S
%A Dequenne P
%A Decomis MP
%J Ann Cardiol Angeiol (Paris)
%V 70
%N 6
%D Dec 2021
%M 34756602
暂无%R 10.1016/j.ancard.2021.10.005
%X Intra coronary thrombus is  frequently encountered during acute coronary syndromes revascularisation procedures. It can also be encountered during angioplasty procedures in a stable angina context, although at a much lesser frequency.In both situations, it harbors a risk of poor angiographic result and poor prognosis. Intracoronnary thrombus may cause coronary occlusion at the angioplasty site or distal embolic  flow obstruction. Per procedure thrombus prevention rests on an prior optimal anti thrombotic treatment and in some circumstances the choice to defer the revascularisation procedure in the complex high risk setting. Treating the initiated thrombus remains controversial concerning thrombectomy and GPIIBIIIa inhibitors which are still in use in common practice. No reflow phenomenon is a particularly complex setting during cornary angioplasties, partially but not solely related to a thrombotic complication. It's treatment remains unclear in the absence of related oriented studies.The current mechanical and pharmacological antithrombotic therapies must remain common practice and used appropriately as of the clinical and angiographic setting, until further scientific outbrakes.